TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹19,681 Cr | ₹16,854 Cr | ₹16,705 Cr | ₹16,321 Cr | ₹15,211 Cr |
| Sales | ₹19,454 Cr | ₹16,655 Cr | ₹16,540 Cr | ₹16,164 Cr | ₹15,122 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹227 Cr | ₹199 Cr | ₹166 Cr | ₹156 Cr | ₹89 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹13,980 Cr | ₹11,516 Cr | ₹10,728 Cr | ₹9,620 Cr | ₹8,508 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹11 Cr | ₹-275 Cr | ₹-155 Cr | ₹166 Cr | ₹74 Cr |
| Raw Material Consumed | ₹3,113 Cr | ₹2,831 Cr | ₹2,614 Cr | ₹2,347 Cr | ₹2,157 Cr |
| Opening Raw Materials | ₹619 Cr | ₹630 Cr | ₹752 Cr | ₹841 Cr | ₹985 Cr |
| Purchases Raw Materials | ₹1,714 Cr | ₹1,288 Cr | ₹1,308 Cr | ₹1,170 Cr | ₹1,182 Cr |
| Closing Raw Materials | ₹840 Cr | ₹619 Cr | ₹630 Cr | ₹752 Cr | ₹841 Cr |
| Other Direct Purchases / Brought in cost | ₹1,619 Cr | ₹1,531 Cr | ₹1,184 Cr | ₹1,089 Cr | ₹831 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹161 Cr | ₹137 Cr | ₹145 Cr | ₹155 Cr | ₹144 Cr |
| Electricity & Power | ₹161 Cr | ₹137 Cr | ₹145 Cr | ₹155 Cr | ₹144 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹2,671 Cr | ₹2,203 Cr | ₹1,984 Cr | ₹1,678 Cr | ₹1,526 Cr |
| Salaries, Wages & Bonus | ₹2,281 Cr | ₹1,898 Cr | ₹1,695 Cr | ₹1,433 Cr | ₹1,305 Cr |
| Contributions to EPF & Pension Funds | ₹219 Cr | ₹186 Cr | ₹178 Cr | ₹153 Cr | ₹134 Cr |
| Workmen and Staff Welfare Expenses | ₹87 Cr | ₹81 Cr | ₹77 Cr | ₹63 Cr | ₹60 Cr |
| Other Employees Cost | ₹83 Cr | ₹37 Cr | ₹34 Cr | ₹29 Cr | ₹28 Cr |
| Other Manufacturing Expenses | ₹744 Cr | ₹594 Cr | ₹571 Cr | ₹571 Cr | ₹591 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹136 Cr | ₹107 Cr | ₹96 Cr | ₹84 Cr | ₹88 Cr |
| Repairs and Maintenance | - | - | - | - | - |
| Packing Material Consumed | ₹264 Cr | ₹220 Cr | ₹227 Cr | ₹222 Cr | ₹211 Cr |
| Other Mfg Exp | ₹344 Cr | ₹268 Cr | ₹248 Cr | ₹265 Cr | ₹292 Cr |
| General and Administration Expenses | ₹1,154 Cr | ₹961 Cr | ₹981 Cr | ₹775 Cr | ₹638 Cr |
| Rent , Rates & Taxes | - | - | - | - | - |
| Insurance | - | - | - | - | - |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹204 Cr | ₹135 Cr | ₹185 Cr | ₹137 Cr | ₹111 Cr |
| Traveling and conveyance | ₹251 Cr | ₹220 Cr | ₹206 Cr | ₹158 Cr | ₹82 Cr |
| Other Administration | ₹699 Cr | ₹606 Cr | ₹590 Cr | ₹480 Cr | ₹445 Cr |
| Selling and Distribution Expenses | ₹1,491 Cr | ₹1,261 Cr | ₹1,130 Cr | ₹1,027 Cr | ₹885 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | - | - | - | - | - |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹1,491 Cr | ₹1,261 Cr | ₹1,130 Cr | ₹1,027 Cr | ₹885 Cr |
| Miscellaneous Expenses | ₹262 Cr | ₹100 Cr | ₹95 Cr | ₹77 Cr | ₹62 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | ₹5.54 Cr | ₹1.77 Cr | ₹7.08 Cr | ₹2.27 Cr | ₹0.90 Cr |
| Losson disposal of fixed assets(net) | - | - | ₹0.02 Cr | - | - |
| Losson foreign exchange fluctuations | ₹183 Cr | ₹17 Cr | ₹3.91 Cr | ₹18 Cr | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹73 Cr | ₹81 Cr | ₹84 Cr | ₹57 Cr | ₹61 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹9,607 Cr | ₹7,812 Cr | ₹7,364 Cr | ₹6,796 Cr | ₹6,077 Cr |
| Operating Profit (Excl OI) | ₹4,373 Cr | ₹3,704 Cr | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr |
| Other Income | ₹92 Cr | ₹40 Cr | ₹62 Cr | ₹63 Cr | ₹197 Cr |
| Interest Received | ₹38 Cr | ₹20 Cr | ₹11 Cr | ₹15 Cr | ₹7.15 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹18 Cr | ₹1.34 Cr | - | ₹22 Cr | - |
| Profits on sale of Investments | ₹33 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹9.88 Cr |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | - | - | - | - | ₹170 Cr |
| Others | ₹2.82 Cr | ₹1.62 Cr | ₹32 Cr | ₹7.45 Cr | ₹9.99 Cr |
| Operating Profit | ₹4,465 Cr | ₹3,744 Cr | ₹3,426 Cr | ₹2,887 Cr | ₹2,628 Cr |
| Interest | ₹385 Cr | ₹252 Cr | ₹354 Cr | ₹333 Cr | ₹255 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹0.38 Cr | ₹0.93 Cr | ₹0.93 Cr | ₹1.20 Cr | ₹2.13 Cr |
| Other Interest | ₹385 Cr | ₹251 Cr | ₹353 Cr | ₹332 Cr | ₹253 Cr |
| PBDT | ₹4,080 Cr | ₹3,492 Cr | ₹3,072 Cr | ₹2,554 Cr | ₹2,373 Cr |
| Depreciation | ₹1,119 Cr | ₹795 Cr | ₹808 Cr | ₹707 Cr | ₹662 Cr |
| Profit Before Taxation & Exceptional Items | ₹2,961 Cr | ₹2,697 Cr | ₹2,264 Cr | ₹1,847 Cr | ₹1,711 Cr |
| Exceptional Income / Expenses | ₹-89 Cr | ₹-24 Cr | ₹88 Cr | - | ₹-485 Cr |
| Profit Before Tax | ₹2,872 Cr | ₹2,673 Cr | ₹2,352 Cr | ₹1,847 Cr | ₹1,226 Cr |
| Provision for Tax | ₹734 Cr | ₹762 Cr | ₹696 Cr | ₹602 Cr | ₹449 Cr |
| Current Income Tax | ₹852 Cr | ₹618 Cr | ₹470 Cr | ₹355 Cr | ₹346 Cr |
| Deferred Tax | ₹-106 Cr | ₹146 Cr | ₹220 Cr | ₹228 Cr | ₹107 Cr |
| Other taxes | ₹-11 Cr | ₹-3.33 Cr | ₹4.98 Cr | ₹20 Cr | ₹-4.02 Cr |
| Profit After Tax | ₹2,138 Cr | ₹1,911 Cr | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹25 Cr | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹2,163 Cr | ₹1,911 Cr | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹4,747 Cr | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr | ₹2,806 Cr |
| Appropriations | ₹6,910 Cr | ₹5,854 Cr | ₹4,960 Cr | ₹4,162 Cr | ₹3,584 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹205 Cr | ₹227 Cr | ₹273 Cr | ₹385 Cr | ₹244 Cr |
| Equity Dividend % | ₹760.00 | ₹640.00 | ₹560.00 | ₹440.00 | ₹960.00 |
| Earnings Per Share | ₹63.92 | ₹56.47 | ₹48.94 | ₹36.79 | ₹45.92 |
| Adjusted EPS | ₹63.92 | ₹56.47 | ₹48.94 | ₹36.79 | ₹22.96 |
Compare Income Statement of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹151,078.7 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
| MANKIND PHARMA | ₹97,332.8 Cr | -0.6% | -5.9% | 0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0% |
1.3% |
40.1% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses